Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors

European Journal of Gynaecological Oncology

Volumn 24, Issue 5, 2003, Pages 417-420

  Ozalp, S ^a   Tanir, H M ^a   Yalcin, O T ^a   Kabukcuoglu, S ^a   Oner, U ^a   Uray, M ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Epithelial ovarian cancer; Matrix metalloproteinase 9; Prognosis

Indexed keywords

GELATINASE B;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; OVARY CANCER; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0141918483     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Niedbala M.J., Crickard K., Bernacki R.J.: "In vitro degradation of extracellular matrix by human ovarian carcinoma cells". Clin. Exp. Metast., 1987, 5, 181.
2. Wu X., Li H., Kang L., Li L., Wang W., Shan B.: "Activated matrix metalloproteinase 2 - a potential marker of prognosis for epithelial ovarian cancer". Gynecol. Oncol., 2002, 84, 126.
3. Tamakoshi K., Kikkawa F., Nawa A., Ishikawa H., Mizuno K., Tamakoshi A. et al.: "Characterisation of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically diffferent metastatic form". Cancer, 1995, 76 (12), 2565.
4. Leber T.M., Balkwill F.R.: "Regulation of monocyte MMP-9 production by TNF-a and a tumor-derived soluble factor (MMPSF)". Br. J. Cancer, 1998, 78 (6), 724.
5. Stacks M.S., Ellerbroek S.M., Fishman D.A.: "The role of proteolytic enzymes in the pathology of epithelial ovarian carcinoma (review)". Int. Oncol., 1999, 12, 569.
6. Sinicrope F.A., Ruan S.B., Cleary K.R., Stephens L.C., Lee J.J., Levin B.: "Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis". Cancer Res., 1995, 55, 237.
7. Huang L.W., Garrett P.A., Bell A.D., Welch R.W., Berkowitz S.R., Mok C.S.: "Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors". Gynecol. Oncol., 2000, 77, 369.
8. Mignatti P., Rifkin D.B.: "Biology and biochemistry of proteinases in tumor invasion". Physiol. Rev., 1993, 73, 161.
9. Nagase H., Woesner J.F.: "Matrix metalloproteinases". J. Biol. Chem., 1999, 274, 21491.
10. Bernhard E.J., Gruber S.B., Muschel R.J.: "Direct evidence linking expression of matrix metalloproteinase 9 (92kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells". Proc. Nat. Acad. Sci. USA, 1994, 91, 4293.
11. Brinckerhofff E.C., Rulter J.L., Benbow U.: "Interstitial collagenases as markers of tumor progression". Clin. Cancer Res., 2000, 6, 4823.
12. Nelson A.R., Fingleton B., Rothenberg M.L., Matrisian L.M.: "Matrix metalloproteinases: biologic activity and clinical implications". J. Clin. Oncol., 2000, 18 (5), 1135.
13. Westerlund A., Sarrkkinen M.A., Hörhtya M., Puistola U., Huganen T.T.: "Gelatinase A-immunoreactive protein in ovarian lesions-prognostic value in epithelial ovarian cancer". Gynecol. Oncol., 1999, 75, 91.
14. Lengyel E., Schmalfeldt B., Konik E., Spathe K. et al.: "Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer". Gynecol. Oncol., 2001, 82, 291.
15. Wu X., Li H., Li K., Li L.,Wang W., Sahn B.: "Activated matrix metalloproteinase-2 - a potential marker of prognosis for epithelial ovarian cancer". Gynecol. Oncol., 2002, 84, 126.
16. Davidson D., Goldberg I., Gotheb W.H. et al.: "High levels of MMP-2, MMP-9, MTI-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma". Clin. Exp. Metastasis, 1999, 17 (10), 799.
17. Sakata K., Shigemasa K., Nagai N., Ohama K.: "Expression of matrix metalloproteinase (MMP-2, MMP-9, MTI-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary". Int. J. Oncol., 2002, 17 (4), 673.
18. Paju A., Soesa T., Tervahantiala T. et al.: "The levels of trypsinogen isoenzymes in ovarian tumor cysts are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation". Br. J. Cancer, 2001, 84 (10), 1363.
19. Rodrigues G.C., Haisley C., Hurteau J. et al.: "Regulation of invasion of epithelial ovarian cancer by tumor growth factor-beta". Gynecol. Oncol., 2001, 80 (2), 245.
20. Ahmed N., Pansino F., Clyde R. et al.: "Overexpression of alpha (v) beta 6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade". Carcinogenesis, 2002, 23 (2), 237.
21. Herrera C.A., Xu L., Bucana C.D., Silva el V.G., Gerhenson D.M., Fidler U.: "Expression of metastasis-related genes in human epithelial ovarian tumors". Int. J. Oncol., 2002, 20 (1), 5.
22. Lynch C.C., Matrisian L.M.: "Matrix metalloproteinases in tumor-host cell communication". Differentiation, 2002, 70 (9-10), 561.
23. Kurschat P., Mauch C.: "Mechanisms of metastasis". Clin. Exp. Dermatol., 2000, 25 (6), 482.
24. Fingleton B., Vargo-Gogola T., Crawford H.C., Matrisian L.M.: "Matrilysin (MMP-7) expression selects for cells with reduced sensitivity to apoptosis". Neoplasia, 2001, 3 (6), 459.
25. Coussens L.M., Fingleton B., Matrisian L.M.: "Matrix metalloproteinase inhibitors and cancer: trials and tribulations". Science, 2002, 295 (5564), 2387.